{"mainPropery":{"diseaseId":10419,"diseaseName":"Myotonic dystrophy","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10419/myotonic-dystrophy","synonyms":["Dystrophia myotonica","Myotonia atrophica","Myotonia dystrophica"],"synonyms-with-source":[{"name":"Dystrophia myotonica"},{"name":"Myotonia atrophica","source":"GHR"},{"name":"Myotonia dystrophica","source":"GHR"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"206647"},{"identifierType":"UMLS","identifierId":"C0027126"}]},"diseaseCategories":[{"diseaseTypeId":15,"diseaseTypeName":"Musculoskeletal Diseases"}],"organizations":[{"resourceID":255,"resourceName":"Myotonic Dystrophy Foundation","abbreviation":"","address1":"1004-A O'Reilly Avenue","address2":"","address3":"","address4":"","address5":"","city":"San Francisco","state":"CA","zip":"94129","country":"United States","phone":"+1-415-800-7777","tty":"","tollFree":"1-86-MYOTONIC  (1-866-968-6642)","fax":"","email":"info@myotonic.org","url":"https://www.myotonic.org","freeText":""},{"resourceID":935,"resourceName":"Muscular Dystrophy Association","abbreviation":"MDA","address1":"222 S Riverside Plaza","address2":"Suite 1500","address3":"","address4":"","address5":"","city":"Chicago","state":"IL","zip":"60606","country":"United States","phone":"","tty":"","tollFree":"1-833-275-6321 (Helpline)","fax":"","email":"resourcecenter@mdausa.org","url":"https://www.mda.org","freeText":""},{"resourceID":936,"resourceName":"Muscular Dystrophy UK","abbreviation":"","address1":"61A Great Suffolk Street","address2":"","address3":"","address4":"","address5":"","city":"London","state":"","zip":" SE1 0BU","country":"United Kingdom","phone":" (+44) 0 020 7803 4800","tty":"","tollFree":"0800 652 6352 (Helpline)","fax":"","email":"info@musculardystrophyuk.org","url":"https://www.musculardystrophyuk.org/","freeText":""},{"resourceID":2339,"resourceName":"Myotonic Dystrophy Support Group","abbreviation":"","address1":"19-21 Main Road","address2":"Gedling","address3":"Nottingham","address4":"NG4 3HQ","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"0808 169 1960","tty":"","tollFree":"","fax":"","email":"contact@mdsguk.org","url":"http://www.myotonicdystrophysupportgroup.org/","freeText":""},{"resourceID":3692,"resourceName":"Myotonic Dystrophy Support and Information Facebook Group","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"","phone":"","tty":"","tollFree":"","fax":"","email":"","url":"https://www.facebook.com/groups/150128601730709/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=%28%22myotonic+dystrophy%22%5BMeSH+Terms%5D+OR+%28%22myotonic%22%5BAll+Fields%5D+AND+%22dystrophy%22%5BAll+Fields%5D%29+OR+%22myotonic+dystrophy%22%5BAll+Fields%5D%29+AND+%28%22loattrfull+text%22%5Bsb%5D+AND+%22loattrfree+full+text%22%5Bsb%5D+AND+hasabstract%5Btext%5D+AND+%222007%2F01%2F28%22%5BPDat%5D+%3A+%222009%2F01%2F26%22%5BPDat%5D%29' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Myotonic dystrophy. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Myotonic+dystrophy%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Myotonic dystrophy. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=myotonicdystrophy' target='_blank'>MedlinePlus Genetics</a> contains information on Myotonic dystrophy. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":250,"resourceId":1091,"resourceName":"Myotonic dystrophy","descriptionText":"Mulders SAM et al., <a href='http://hmg.oxfordjournals.org/content/19/R1/R90.full.pdf ' target='_blank'>Molecular therapy in myotonic dystrophy: Focus on RNA gain-of-function</a>. <em>Human Molecular Genetics</em>. 2010:19(1):R90-R97.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":501,"resourceId":1235,"resourceName":"Resources for myotonic dystrophy","descriptionText":"GeneReviews provides current, expert-authored, peer-reviewed, full-text articles on <a href='http://www.ncbi.nlm.nih.gov/books/NBK1165/ ' target='_blank'>myotonic dystrophy type 1</a> and <a href='http://www.ncbi.nlm.nih.gov/books/NBK1466/ ' target='_blank'>myotonic dystrophy type 2</a>. These articles describe the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1402,"resourceId":1091,"resourceName":"Myotonic dystrophy","descriptionText":"<a href='https://www.mda.org/disease/myotonic-muscular-dystrophy' target='_blank'>The Muscular Dystrophy Association</a> (MDA) provides additional information about myotonic dystrophy. Click on the link to view this information.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/357/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1533,"resourceId":2164,"resourceName":"National Center for Biotechnology Information","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/books/NBK22255/' target='_blank'>National Center for Biotechnology Information</a> (NCBI) was established in 1988 as a national resource for molecular biology information.  Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=206647' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1545,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The <a href='http://www.merckmanuals.com/home/sec05/ch073/ch073c.html#sec05-ch073-ch073d-881' target='_blank'>Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1549,"resourceId":2177,"resourceName":"National Human Genome Research Institute","descriptionText":"The <a href='http://www.genome.gov/25521207' target='_blank'>National Human Genome Research Institute's</a> (NHGRI) website has an information page on this topic. NHGRI is part of the National Institutes of Health and supports research on the structure and function of the human genome and its role in health and disease.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1651,"resourceId":255,"resourceName":"Myotonic Dystrophy Foundation","descriptionText":"<a href='http://www.myotonic.org/what-dm/start-here' target='_blank'>The Myotonic Dystrophy Foundation</a> provides additional information about Myotonic dystrophy.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MESH:D009223' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2700,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='https://www.omim.org/phenotypicSeries/PS160900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> lists the subtypes with the clinical characteristics and associated genes for Myotonic dystrophy in a table called Clinical synopsis. Each entry in OMIM includes a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Myotonic dystrophy. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Myotonic dystrophy:<br />\r\n<a href='https://www.urmc.rochester.edu/neurology/national-registry.aspx' target='_blank'>National Registry of Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy</a><br /><a href='https://myotonicregistry.patientcrossroads.org/index.php' target='_blank'>The Myotonic Dystrophy Family Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":2103,"questionText":"What is myotonic dystrophy?","answerText":"<strong><strong>Myotonic dystrophy<em> </em></strong></strong>is a disease that affects the muscles and other body systems. It is the most common form of <a href=\"https://www.ninds.nih.gov/Disorders/All-Disorders/Muscular-Dystrophy-Information-Page\">muscular dystrophy</a> that begins in adulthood, usually in a person&rsquo;s 20s or 30s. This disease is characterized by progressive muscle loss and weakness. Myotonic dystrophy may be further classified into two types, and the two types may affect different muscles. People with myotonic dystrophy usually have prolonged muscle tensing (<a href=\"http://tools.aan.com/apps/disorders/index.cfm?event=database:disorder.view&amp;disorder_id=1005\">myotonia</a>) and are not able to relax certain muscles after use. The severity of the disease may vary among affected people, even among members of the same family.[1286][13721]<br />\r\n<br />\r\nMyotonic dystrophy is caused by <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a> (changes) in the <a href=\"https://ghr.nlm.nih.gov/gene/DMPK\"><em>DMPK</em></a><em> </em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a> or the <a href=\"https://ghr.nlm.nih.gov/gene/CNBP\"><em>CNBP</em><em> (ZNF9)</em></a><em> </em>gene depending on the specific type of myotonic dystrophy. The disease is inherited in an <a href=\"https://medlineplus.gov/ency/article/002049.htm\">autosomal dominant</a> manner.[1286] Myotonic dystrophy may be diagnosed when a healthcare provider observes signs and symptoms of the disease, and the diagnosis may be confirmed with tests of muscle function and <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a>.[348] Treatment is based on each person&rsquo;s specific signs and symptoms and may include <a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapy</a>, pain management with medication, and consultation with specialists.[348][1728]&nbsp;<strong><br />\r\n</strong>","dateModified":"2017-08-21T00:00:00"},"basicQuestions":[{"questionId":2106,"questionText":"What are the signs and symptoms of myotonic dystrophy?","answerText":"Signs and symptoms of myotonic dystrophy often begin in a person&rsquo;s 20s or 30s but can begin at any age. Symptoms often include progressive muscle weakness, stiffness, tightness, and wasting. There are two types of myotonic dystrophy: <a href=\"https://rarediseases.info.nih.gov/diseases/8310/disease\">myotonic dystrophy type 1</a> and <a href=\"https://rarediseases.info.nih.gov/diseases/9728/disease\">myotonic dystrophy type 2</a>. The symptoms in people with myotonic dystrophy type 2 tend to be milder than in those with type 1, but the symptoms may overlap. People with myotonic dystrophy type 1 typically experience involvement of the legs, hands, neck, and face, while people with myotonic dystrophy type 2 typically experience involvement of the neck, shoulders, elbows, and hips. The severity of symptoms can vary widely among affected people. [1286]<br />\r\n<br />\r\nOther signs and symptoms of myotonic dystrophy can include <a href=\"https://medlineplus.gov/cataract.html\">cataracts</a>, <a href=\"https://medlineplus.gov/ency/article/000313.htm\">type-2 diabetes</a>, and <a href=\"https://medlineplus.gov/ency/imagepages/18052.htm\">cardiac conduction</a> defects (irregular electrical control of the heartbeat). Some affected men also have hormonal changes that may cause balding or <a href=\"https://medlineplus.gov/infertility.html\">infertility</a>.[1286][1725] <br />\r\n<br />\r\nIn some cases, babies are born with a variation of myotonic dystrophy type 1 called <a href=\"https://www.mda.org/disease/myotonic-muscular-dystrophy/signs-and-symptoms/congenital-MMD\">congenital myotonic dystrophy.</a> Symptoms of congenital myotonic dystrophy are present from birth and include weakness of all muscles, breathing problems, <a href=\"https://medlineplus.gov/ency/article/001228.htm\">clubfeet</a>, <a href=\"http://www.med.umich.edu/yourchild/topics/devdel.htm\">developmental delays</a> and <a href=\"https://medlineplus.gov/ency/article/001523.htm\">intellectual disabilities</a>.[1286][1728]<br />","dateModified":"2017-08-21T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":1286,"authors":"","articleTitle":"Myotonic dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2010","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/myotonic-dystrophy","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1725,"authors":"","articleTitle":"Learning About Myotonic Dystrophy","bookWebsiteJournalTitle":"National Human Genome Research Institute (NHGRI)","date":"June 5, 2017","volume":"","pages":"","url":"https://www.genome.gov/25521207/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1728,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 22, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1165/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2104,"questionText":"What causes myotonic dystrophy?","answerText":"Myotonic dystrophy is caused by <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a> (changes) in either the <a href=\"https://ghr.nlm.nih.gov/gene/DMPK\"><em>DMPK</em></a><em> </em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a> (in type 1) or the <a href=\"https://ghr.nlm.nih.gov/gene/CNBP\"><em>CNBP (ZNF9)</em></a><em> </em>gene (in type 2). The specific kinds of mutations found in both types of myotonic dystrophy are <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175376/\">trinucleotide repeat expansions</a>. These types of mutations occur when a piece of <a href=\"https://ghr.nlm.nih.gov/primer/basics/dna\">DNA</a> is abnormally repeated a number of times, which makes the gene unstable. The mutated gene makes an altered version of <a href=\"http://www.sciencedirect.com/topics/neuroscience/messenger-rna\">messenger RNA</a> (mRNA), which is a copy of the gene that is normally used for protein production. The abnormal mRNA forms clumps inside the cell that interfere with the production of many proteins. These changes prevent cells in muscles and other tissues from functioning normally, leading to the signs and symptoms of myotonic dystrophy.[1286] <br />\r\n<br />\r\nThe exact functions of the <em>DMPK</em> and <em>CNBP</em> genes are not well understood. <em>DMPK </em>may play a role in communication within cells, specifically in cells of the heart, brain, and skeletal muscles. The <em>CNBP</em> gene gives the body directions to make a protein found mainly in the cells of the heart and skeletal muscles, where it is thought to regulate the activities of other genes.[1286]<br />","dateModified":"2017-08-21T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":1286,"authors":"","articleTitle":"Myotonic dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2010","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/myotonic-dystrophy","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12128,"questionText":"How is myotonic dystrophy inherited?","answerText":"Myotonic dystrophy (DM) is inherited in an <a href=\"https://medlineplus.gov/ency/article/002049.htm\">autosomal dominant</a> pattern.[1286] This means that one copy of the altered <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a> in each cell of the body is enough to cause symptoms of the disease. We inherit one copy of each gene from our mother and the other from our father. Therefore, when a person with myotonic dystrophy goes on to have children, there is a 50% chance that each child will have myotonic dystrophy.&nbsp;<br />\r\n<br />\r\nAny person who has myotonic dystrophy can pass the&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutation</a>&nbsp;on to his or her children, whether the children are male or female. Myotonic dystrophy type 1 exhibits an unusual genetic pattern called&nbsp;<a href=\"https://ghr.nlm.nih.gov/primer/inheritance/anticipation\">anticipation</a>.[1728] Anticipation means the signs and symptoms of a genetic disease begin earlier in life and become more severe as the disease is passed on through generations.&nbsp;Congenital myotonic dystrophy type 1 occurs only when the disease is inherited from the mother.","dateModified":"2018-01-03T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":1286,"authors":"","articleTitle":"Myotonic dystrophy","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2010","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/myotonic-dystrophy","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1728,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 22, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1165/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12129,"questionText":"How is myotonic dystrophy diagnosed?","answerText":"Myotonic dystrophy is diagnosed by doing a physical exam. A physical exam can identify the typical pattern of muscle wasting and weakness of the jaw and neck muscles and the presence of <a href=\"http://tools.aan.com/apps/disorders/index.cfm?event=database:disorder.view&amp;disorder_id=1005\">myotonia</a>. Men may have frontal balding.[348][1728]<br />\r\n<br />\r\nThere are several laboratory tests that can be used to clarify the clinical diagnosis of myotonic dystrophy. One test, called <a href=\"http://www.hopkinsmedicine.org/healthlibrary/test_procedures/neurological/electromyography_emg_92,P07656/\">electromyography (EMG),</a> involves inserting a small needle into the muscle. The electrical activity of the muscle is studied and usually shows characteristic patterns of myotonic dystrophy.[348] Other laboratory tests may include a <a href=\"https://medlineplus.gov/ency/article/003924.htm\">muscle biopsy</a>, which can be used to determine if the muscle fibers are weaker than they should be (atrophied), or a blood test to determine if there are elevated levels of certain muscle <a href=\"https://medlineplus.gov/ency/article/002353.htm\">enzymes</a>.[348][13722]<br />\r\n<br />\r\nThe definitive test for myotonic dystrophy is a <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic test</a>. For this test, a blood or saliva sample is analyzed to determine if there is a <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutation</a> in the <a href=\"https://ghr.nlm.nih.gov/gene/DMPK\"><em>DMPK</em></a><em> </em>or <a href=\"https://ghr.nlm.nih.gov/gene/CNBP\"><em>CNBP (ZNF9)</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">genes</a>.[348][1728][13723]<br />\r\n<br />\r\nThe University of Washington provides more information on&nbsp;genetic testing&nbsp;for&nbsp;myotonic dystrophy in their publication titled, \"<a href=\"http://depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf\" target=\"_blank\">Myotonic Dystrophy: Making an Informed Choice About Genetic Testing</a>.\"&nbsp;<br />","dateModified":"2018-04-20T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":348,"authors":"Dalton JC, Ranum LPW, and Day JW","articleTitle":"Myotonic Dystrophy Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"July 3, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1466/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1728,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 22, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1165/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13722,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/dystrophy-myotonic/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13723,"authors":"O’Sullivan Smith C, Bennett RL, and Bird TD","articleTitle":"Myotonic Dystrophy: Making an Informed Choice About Genetic Testing","bookWebsiteJournalTitle":"Department of Neurology, University of Washington School of Medicine","date":"","volume":"","pages":"","url":"http://depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":2107,"questionText":"What treatment is available for myotonic dystrophy?","answerText":"There is currently no cure or specific treatment for myotonic dystrophy.[1725] Treatment is aimed at managing symptoms of the disease.[13723] Routine physical activity appears to help maintain muscle strength and endurance and to control musculoskeletal pain.[348] Canes, braces, walkers, and scooters can help as muscle weakness progresses.[1725]<br />\r\n<br />\r\nThere are also medications that can lessen pain associated with myotonic dystrophy.[1725] Pain management can be achieved through the use of medications prescribed by a doctor.[1728][1726] Heart problems associated with myotonic dystrophy can be treated through the insertion of a <a href=\"https://medlineplus.gov/ency/article/007369.htm\">pacemaker</a>, medications, and regular monitoring of cardiac function. Cataracts can be surgically removed. <a href=\"http://www.webmd.com/men/guide/testosterone-replacement-therapy-is-it-right-for-you\">Testosterone replacement therapy</a> may be used to treat infertility in males.[1726]<br />\r\n<br />\r\nCurrent research is focusing on how we might be able to one day use gene-editing technology or other treatments to remove the clumps of RNA that cause the symptoms of myotonic dystrophy. However, this therapy is not yet possible in humans.[13724][13725]<br />\r\n<br />\r\nGeneReviews has more detailed information about the management of <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1165/\">myotonic dystrophy type 1</a> and <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK1466/\">type 2</a>.&nbsp;<br />","dateModified":"2017-08-21T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":348,"authors":"Dalton JC, Ranum LPW, and Day JW","articleTitle":"Myotonic Dystrophy Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"July 3, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1466/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1725,"authors":"","articleTitle":"Learning About Myotonic Dystrophy","bookWebsiteJournalTitle":"National Human Genome Research Institute (NHGRI)","date":"June 5, 2017","volume":"","pages":"","url":"https://www.genome.gov/25521207/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1726,"authors":"","articleTitle":"Adult-Onset MMD1/MMD2 and Juvenile-Onset MMD1","bookWebsiteJournalTitle":"Muscular Dystrophy Association (MDA)","date":"2017","volume":"","pages":"","url":"https://www.mda.org/disease/myotonic-muscular-dystrophy/medical-management/adult-mmd1-mmd2-juvenile-mmd1","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1728,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy Type 1","bookWebsiteJournalTitle":"GeneReviews","date":"October 22, 2015","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK1165/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13723,"authors":"O’Sullivan Smith C, Bennett RL, and Bird TD","articleTitle":"Myotonic Dystrophy: Making an Informed Choice About Genetic Testing","bookWebsiteJournalTitle":"Department of Neurology, University of Washington School of Medicine","date":"","volume":"","pages":"","url":"http://depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13724,"authors":"Batra R, Nelles DA, Pirie E, Blue SM, Marina RJ, Wang H, Chaim IA, Thomas JD, Zhang N, Nguyen V, Aigner S, Markmiller S, Xia G, Corbett KD, Swanson MS, and Yeo GW","articleTitle":"Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9","bookWebsiteJournalTitle":"Cell","date":"August 8, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28803727","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13725,"authors":"Konieczny P, Selma-Soriano E, Rapisarda AS, Fernandez-Costa JM, Perez-Alonso M, and Artero R","articleTitle":"Myotonic dystrophy: candidate small molecule therapeutics","bookWebsiteJournalTitle":"Drug Discovery Today","date":"August 2, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28780071","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7382,"questionText":"What is the long-term outlook for people with myotonic dystrophy?","answerText":"The long-term outlook (prognosis) for each person with myotonic dystrophy (including life expectancy) may depend on the type of myotonic dystrophy and the specific medical problems present. Myotonic dystrophy is a progressive disease, meaning that symptoms worsen as a person gets older.[13726]<br />\r\n<br />\r\nAlthough evidence is limited, life expectancy appears to be reduced for people with myotonic dystrophy type 1 (DM1). The most common causes of death in people with DM1 are respiratory and cardiac (heart) symptoms. An increased risk of death may be associated with younger age of onset, more severe muscle weakness, and <a href=\"https://medlineplus.gov/ency/imagepages/18052.htm\">cardiac conduction</a> defects. People with more mild symptoms of DM1 may have a normal lifespan.[13727]<br />\r\n<br />\r\nDefinitive information about prognosis in people with myotonic dystrophy type 2 is limited, but the condition generally runs a milder course. People with myotonic dystrophy type 2 may have a normal lifespan.[13727] While mobility may be impaired at an early age, the ability to walk is often retained until around 60-years-old.[348]<br />","dateModified":"2017-08-22T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":348,"authors":"Dalton JC, Ranum LPW, and Day JW","articleTitle":"Myotonic Dystrophy Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"July 3, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1466/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13726,"authors":"","articleTitle":"Managing DM: FAQs","bookWebsiteJournalTitle":"Myotonic Dystrophy Foundation","date":"","volume":"","pages":"","url":"http://www.myotonic.org/what-dm/faqs","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13727,"authors":"Darras BT and Chad DA","articleTitle":"Myotonic dystrophy: Etiology, clinical features, and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"June 6, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/myotonic-dystrophy-etiology-clinical-features-and-diagnosis#H191953850","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":13721,"authors":"","articleTitle":"Myotonic Dystrophy 1; DM1","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"July 6, 2017","volume":"","pages":"","url":"https://www.omim.org/entry/160900","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":348,"authors":"Dalton JC, Ranum LPW, and Day JW","articleTitle":"Myotonic Dystrophy Type 2","bookWebsiteJournalTitle":"GeneReviews","date":"July 3, 2013","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1466/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1725,"authors":"","articleTitle":"Learning About Myotonic Dystrophy","bookWebsiteJournalTitle":"National Human Genome Research Institute (NHGRI)","date":"June 5, 2017","volume":"","pages":"","url":"https://www.genome.gov/25521207/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13722,"authors":"Bird TD","articleTitle":"Myotonic Dystrophy","bookWebsiteJournalTitle":"National Organization for Rare Disorders","date":"2017","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/dystrophy-myotonic/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13723,"authors":"O’Sullivan Smith C, Bennett RL, and Bird TD","articleTitle":"Myotonic Dystrophy: Making an Informed Choice About Genetic Testing","bookWebsiteJournalTitle":"Department of Neurology, University of Washington School of Medicine","date":"","volume":"","pages":"","url":"http://depts.washington.edu/neurolog/images/neurogenetics/myotonic.pdf","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":1726,"authors":"","articleTitle":"Adult-Onset MMD1/MMD2 and Juvenile-Onset MMD1","bookWebsiteJournalTitle":"Muscular Dystrophy Association (MDA)","date":"2017","volume":"","pages":"","url":"https://www.mda.org/disease/myotonic-muscular-dystrophy/medical-management/adult-mmd1-mmd2-juvenile-mmd1","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13724,"authors":"Batra R, Nelles DA, Pirie E, Blue SM, Marina RJ, Wang H, Chaim IA, Thomas JD, Zhang N, Nguyen V, Aigner S, Markmiller S, Xia G, Corbett KD, Swanson MS, and Yeo GW","articleTitle":"Elimination of Toxic Microsatellite Repeat Expansion RNA by RNA-Targeting Cas9","bookWebsiteJournalTitle":"Cell","date":"August 8, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28803727","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13725,"authors":"Konieczny P, Selma-Soriano E, Rapisarda AS, Fernandez-Costa JM, Perez-Alonso M, and Artero R","articleTitle":"Myotonic dystrophy: candidate small molecule therapeutics","bookWebsiteJournalTitle":"Drug Discovery Today","date":"August 2, 2017","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/pubmed/28780071","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13726,"authors":"","articleTitle":"Managing DM: FAQs","bookWebsiteJournalTitle":"Myotonic Dystrophy Foundation","date":"","volume":"","pages":"","url":"http://www.myotonic.org/what-dm/faqs","dateAccessed":"2017-08-16T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13727,"authors":"Darras BT and Chad DA","articleTitle":"Myotonic dystrophy: Etiology, clinical features, and diagnosis","bookWebsiteJournalTitle":"UpToDate","date":"June 6, 2017","volume":"","pages":"","url":"https://www.uptodate.com/contents/myotonic-dystrophy-etiology-clinical-features-and-diagnosis#H191953850","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":9134,"relatedDiseaseName":"Congenital myotonic dystrophy","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":7922,"relatedDiseaseName":"Muscular dystrophy","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":9135,"relatedDiseaseName":"Muscular Dystrophy - Late Onset","relation":"Parent","isRare":true,"hasGardPage":true},{"relatedDiseaseId":8310,"relatedDiseaseName":"Myotonic dystrophy type 1","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":9728,"relatedDiseaseName":"Myotonic dystrophy type 2","relation":"Child","isRare":true,"hasGardPage":true},{"relatedDiseaseId":12583,"relatedDiseaseName":"Progressive muscular dystrophy","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Myotonic_dystrophy"}